Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com
Investment analysts at StockNews.com began coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Trading Up 3.0 % Shares of NASDAQ CYCC opened at $0.23 on Wednesday. The company has a market cap of […]
Investment analysts at StockNews.com began coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Trading Up 3.0 % Shares of NASDAQ CYCC opened at $0.23 on Wednesday. The company has a market cap of […]
